engleski

The 5th FESCC Continuous Postgraduate Course in Clinical Chemistry: New trends in classification, monitoring and management of autoimmune diseases

Editorial: The Fifth FESCC Continuous Postgraduate Course in Clinical Chemistry: New Trends in Classification, Monitoring and Management of Autoimmune Diseases The Croatian Society of Medical Biochemists and Slovenian Association for Clinical Chemistry, together with the Forum of the European Societies of Clinical Chemistry (FESCC) - IFCC in Europe have organized the fifth in a series of postgraduate weekend courses entitled “ New Trends in Classification, Monitoring and Management of Autoimmune Diseases” promoting continuous postgraduate education of experts in clinical chemistry and laboratory medicine, and ensuring the laboratory knowledge harmonization, this time on autoimmune diseases in particular. In the past few years, scientists have made some important breakthroughs in understanding the many types of autoimmune disease. These findings are now opening the way to new horizons for diagnosing and monitoring of these disorders. Renowned experts from European countries have participated in this specialized FESCC Course covering the clinical and laboratory aspects of autoimmune diseases. This Handbook contains the material prepared by these experts especially for this Course. The integrated knowledge of the authors, experts in different fields, is intended to provide the reader with optimal information. The Handbook contents is divided into three chapters acorrding to the Course program. The chapter BASIC CONCEPTS covers topics such as New aspects on the immunopathogenesis of autoimmune disease ; Genetics of autoimmune disease ; Autoimmune aspects of pregnancy and infertility ; Apoptosis and Autoimmunity. In the chapter NEW APPROACH TO DIAGNOSIS, Laboratory standards in the diagnosis and therapy monitoring of autoimmune diseases such as Celiac disease, Rheumatoid arthritis, Vasculitis, Multiple sclerosis and SLE are described. The last chapter is dedicated to EVIDENCE BASED DIAGNOSIS AND QUALITY ASSURANCE where Quality assurance and organization of autoantibody laboratory ; Statistical management on autoimmune diseases data ; Guidelines for ANA testing ; and Therapeutic potential in autoimmune disease are presented. We do hope that the Course program as well as this Course Handbook meets the intended goals by presenting the state-of-the-art and contributing to harmonization of the classification, monitoring and management of autoimmune disease.

autoimmune diseases

nije evidentirano